Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob F Oyeniyi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cureus|November 10, 2025
Management of Low-Grade Ductal Carcinoma In Situ in a Supernumerary Breast: A Case ReportAlicia Bui, Jacob F Oyeniyi, Bailey A Loving, et al.
Cancers|January 11, 2025
The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell LinesKumari Alka, Jacob F Oyeniyi, Ghulam Mohammad, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|April 30, 2025
Optimizing posterior neck coverage in regional nodal irradiation for breast cancerJacob F Oyeniyi, Bailey A Loving, Thomas J Quinn, et al.
Cancer Causes & Control : CCC|March 20, 2025
Leveraging technology and standardized institutional practices to mitigate disparities in breast cancer radiation therapyJacob F Oyeniyi, Bailey A Loving, Muayad F Almahariq, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 23, 2024
Socioeconomic disadvantage and its impact on patient satisfaction at a multi-site radiation oncology centerBailey A Loving, Allison J Hazy, Kamran F Salari, et al.
JCI Insight|December 9, 2025
Enhanced lipid metabolism serves as a metabolic vulnerability to polyunsaturated fatty acids in glioblastomaShiva Kant, Yi Zhao, Pravin Kesarwani, et al.
Clinical and Translational Radiation Oncology|June 9, 2025
Outcomes and predictive factors after second stereotactic radiosurgery for refractory trigeminal neuralgiaBailey A Loving, Jacob F Oyeniyi, Siddharth Ramanathan, et al.
Brachytherapy|November 20, 2025
MRI-based predictors of treatment failure in intermediate-risk prostate cancer treated with high-dose-rate brachytherapy as monotherapyJacob F Oyeniyi, Joseph S Lee, Chen Shen, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cureus|November 10, 2025
Management of Low-Grade Ductal Carcinoma In Situ in a Supernumerary Breast: A Case ReportAlicia Bui, Jacob F Oyeniyi, Bailey A Loving, et al.
Cancers|January 11, 2025
The RAGE Inhibitor TTP488 (Azeliragon) Demonstrates Anti-Tumor Activity and Enhances the Efficacy of Radiation Therapy in Pancreatic Cancer Cell LinesKumari Alka, Jacob F Oyeniyi, Ghulam Mohammad, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|April 30, 2025
Optimizing posterior neck coverage in regional nodal irradiation for breast cancerJacob F Oyeniyi, Bailey A Loving, Thomas J Quinn, et al.
Cancer Causes & Control : CCC|March 20, 2025
Leveraging technology and standardized institutional practices to mitigate disparities in breast cancer radiation therapyJacob F Oyeniyi, Bailey A Loving, Muayad F Almahariq, et al.
Technical Innovations & Patient Support in Radiation Oncology|September 23, 2024
Socioeconomic disadvantage and its impact on patient satisfaction at a multi-site radiation oncology centerBailey A Loving, Allison J Hazy, Kamran F Salari, et al.
JCI Insight|December 9, 2025
Enhanced lipid metabolism serves as a metabolic vulnerability to polyunsaturated fatty acids in glioblastomaShiva Kant, Yi Zhao, Pravin Kesarwani, et al.
Clinical and Translational Radiation Oncology|June 9, 2025
Outcomes and predictive factors after second stereotactic radiosurgery for refractory trigeminal neuralgiaBailey A Loving, Jacob F Oyeniyi, Siddharth Ramanathan, et al.
Brachytherapy|November 20, 2025
MRI-based predictors of treatment failure in intermediate-risk prostate cancer treated with high-dose-rate brachytherapy as monotherapyJacob F Oyeniyi, Joseph S Lee, Chen Shen, et al.
Pageof 1